March 26, 2018 / 11:40 AM / a month ago

BRIEF-Evoke Announces Agreement With Mallinckrodt To Amend Milestone Payments

March 26 (Reuters) - Evoke Pharma Inc:

* EVOKE ANNOUNCES AGREEMENT WITH MALLINCKRODT TO AMEND MILESTONE PAYMENTS

* ‍HAS AMENDED CO’S AGREEMENT WITH MALLINCKRODT, ARD INC. TO DEFER DEVELOPMENT AND APPROVAL MILESTONE PAYMENTS FOR GIMOTI​

* AMENDED AGREEMENT DEFERS AMOUNT AND TIMING OF TWO MILESTONE PAYMENTS​

* ‍AMENDED AGREEMENT DEFERS AMOUNT AND TIMING OF TWO MILESTONE PAYMENTS DUE UPON U.S. FDA ACCEPTANCE FOR REVIEW OF NEW DRUG APPLICATION​

* EVOKE PHARMA - HAVE IMPROVED CASH RUNWAY TO JANUARY OF NEXT YEAR AND REMAIN ON TRACK TO SUBMIT GIMOTI NDA NEXT QUARTER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below